MSH2 and small intestine cancer: These studies often did not distinguish between gastric and small intestinal cancers or only included duodenal SIAs, suggesting a potential different risk profile for SIA specifically in MSH2 and MLH1 carriers compared to other upper gastrointestinal cancers.